Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019)

Ironwood Pharmaceuticals (IRWD) posted Divestments of -$4.2 million for Q1 2019, down 38.6% sequentially from -$3.0 million in Q4 2018.

Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has reported Divestments for 3 years, with the latest figure at -$4.2 million in Q1 2019.

Quarterly Divestments changed N/A year-over-year to -$4.2 million in Q1 2019, while the trailing twelve-month figure through Dec 2019 was -$4.2 million (up 35.19% YoY) and the FY2019 annual result came in at -$4.2 million, up 48.94% from the prior year.
Divestments declined to -$4.2 million in Q1 2019 per IRWD's latest filing, from -$3.0 million in the prior quarter.
Over five years, Divestments peaked at -$3.0 million in Q4 2018 and troughed at -$4.2 million in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	65.64 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Ironwood Pharmaceuticals	679.81 Mn	600.69 Mn	-	-

Download Data